337 related articles for article (PubMed ID: 30314595)
1. Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.
de Natale ER; Niccolini F; Wilson H; Politis M
Int Rev Neurobiol; 2018; 141():131-172. PubMed ID: 30314595
[TBL] [Abstract][Full Text] [Related]
2. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
3. SPECT imaging of the dopaminergic system in (premotor) Parkinson's disease.
Booij J; Knol RJ
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S425-8. PubMed ID: 18267276
[TBL] [Abstract][Full Text] [Related]
4. [Molecular imaging in Parkinson's disease].
Arahata Y; Kato T; Ito K
Nihon Rinsho; 2007 Feb; 65(2):327-31. PubMed ID: 17302279
[TBL] [Abstract][Full Text] [Related]
5. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
Thobois S; Guillouet S; Broussolle E
Neurophysiol Clin; 2001 Oct; 31(5):321-40. PubMed ID: 11817273
[TBL] [Abstract][Full Text] [Related]
6. PET studies of the striatal dopaminergic system in Parkinson's disease (PD).
Piccini P; Turjanski N; Brooks DJ
J Neural Transm Suppl; 1995; 45():123-31. PubMed ID: 8748617
[TBL] [Abstract][Full Text] [Related]
7. Radiotracers for imaging of Parkinson's disease.
Abbasi Gharibkandi N; Hosseinimehr SJ
Eur J Med Chem; 2019 Mar; 166():75-89. PubMed ID: 30685535
[TBL] [Abstract][Full Text] [Related]
8. Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.
Arena JE; Stoessl AJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S47-51. PubMed ID: 26439947
[TBL] [Abstract][Full Text] [Related]
9. [Functional neuroimaging in movement disorders].
Borbély K
Orv Hetil; 2001 Oct; 142(43):2347-55. PubMed ID: 11760452
[TBL] [Abstract][Full Text] [Related]
10. SPECT Molecular Imaging in Familial Parkinson's Disease.
Varrone A; Pellecchia MT
Int Rev Neurobiol; 2018; 142():225-260. PubMed ID: 30409254
[TBL] [Abstract][Full Text] [Related]
11. Dopamine receptor mapping with PET imaging in Parkinson's disease.
Niccolini F; Su P; Politis M
J Neurol; 2014 Dec; 261(12):2251-63. PubMed ID: 24627109
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease and dopamine transporter neuroimaging: a critical review.
Shih MC; Hoexter MQ; Andrade LA; Bressan RA
Sao Paulo Med J; 2006 May; 124(3):168-75. PubMed ID: 17119698
[TBL] [Abstract][Full Text] [Related]
13. Functional imaging in pre-motor Parkinson's disease.
Arnaldi D; Morbelli S; Picco A; Ferrara M; Buschiazzo A; Famà F; De Carli F; Nobili F
Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):366-75. PubMed ID: 25366709
[TBL] [Abstract][Full Text] [Related]
14. PET and SPECT studies in Parkinson's disease.
Brooks DJ
Baillieres Clin Neurol; 1997 Apr; 6(1):69-87. PubMed ID: 9426869
[TBL] [Abstract][Full Text] [Related]
15. PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences.
Thobois S; Jahanshahi M; Pinto S; Frackowiak R; Limousin-Dowsey P
Neuroimage; 2004 Sep; 23(1):1-16. PubMed ID: 15325346
[TBL] [Abstract][Full Text] [Related]
16. Molecular Imaging of Addictive Behavior in Idiopathic Parkinson's Disease.
Ghadery C; Valli M; Mihaescu A; Strafella R; Navalpotro I; Kim J; Strafella AP
Int Rev Neurobiol; 2018; 141():365-404. PubMed ID: 30314604
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool.
Nicastro N; Nencha U; Burkhard PR; Garibotto V
J Neurochem; 2023 Feb; 164(3):346-363. PubMed ID: 34935143
[TBL] [Abstract][Full Text] [Related]
18. PET Molecular Imaging in Familial Parkinson's Disease.
Matarazzo M; Wile D; Mackenzie M; Stoessl AJ
Int Rev Neurobiol; 2018; 142():177-223. PubMed ID: 30409253
[TBL] [Abstract][Full Text] [Related]
19. Imaging beyond the striatonigral dopaminergic system in Parkinson's disease.
Giza E; Gotzamani-Psarrakou A; Bostantjopoulou S
Hell J Nucl Med; 2012; 15(3):224-32. PubMed ID: 23106055
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders.
Shen LH; Liao MH; Tseng YC
J Biomed Biotechnol; 2012; 2012():259349. PubMed ID: 22570524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
